What's next for the business of longevity? - The New York Times

DealBook spoke with the Harvard researcher and biotech founder David Sinclair about the opportunities and challenges of hacking the human lifespan.

Related Keywords

United States ,Americans , ,Drug Administration ,Unity Biotechnology ,Social Security ,Longevity ,David Andrew Sinclair ,